000			01936 a2200505 4500
005			20250515112933.0
264		0	_c20080709
008			200807s 0 0 eng d
022			_a1173-2563
024	7		_a10.2165/00044011-200828040-00004 _2doi
040			_aNLM _beng _cNLM
100	1		_aGolden, Gil
245	0	0	_aBioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia. _h[electronic resource]
260			_bClinical drug investigation _c2008
300			_a231-9 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntipsychotic Agents _xadministration & dosage
650	0	4	_aArea Under Curve
650	0	4	_aClozapine _xadministration & dosage
650	0	4	_aCross-Over Studies
650	0	4	_aDisorders of Excessive Somnolence _xchemically induced
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrugs, Generic _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aIntestinal Obstruction _xchemically induced
650	0	4	_aIntestine, Small _xdrug effects
650	0	4	_aMale
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMiddle Aged
650	0	4	_aPatient Dropouts _xstatistics & numerical data
650	0	4	_aPatient Satisfaction
650	0	4	_aSchizophrenia _xdrug therapy
650	0	4	_aSweating _xdrug effects
650	0	4	_aTablets
650	0	4	_aTherapeutic Equivalency
700	1		_aHonigfeld, Gilbert
773	0		_tClinical drug investigation _gvol. 28 _gno. 4 _gp. 231-9
856	4	0	_uhttps://doi.org/10.2165/00044011-200828040-00004 _zAvailable from publisher's website
999			_c17847170 _d17847170